v3.26.1
Liquidity Capital Resources and Going Concern (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Cash and cash equivalents $ 1,776,259   $ 2,149,015   $ 1,776,259 $ 2,149,015 $ 3,198,682 $ 10,651,644
Accumulated deficit (57,204,456)       (57,204,456)   (49,936,598)  
Net Income (loss) (2,696,235) $ (4,571,623) $ (4,580,448) $ (3,698,414) (7,267,858) (8,278,862)    
Net cash used in operations         (2,297,376)      
Proceeds from issuance of debt         2,960,000      
Net proceeds of ATM         0 $ (1,781) $ 8,909,000  
Working capital $ 2,419,543       $ 2,419,543      
Non- affiliate [Member]                
Description of remaining availability under sales agreement         the aggregate market value of our outstanding common stock held by non-affiliates, or the public float, was approximately $39,144,000, which was calculated based on 11,184,116 outstanding shares of the Company’s common stock held by non-affiliates at a price of $3.50 per share, the closing price of our common stock on March 25, 2026, as reported on Nasdaq. Pursuant to General Instruction I.B.6 of Form S-3, or the “baby shelf” rules, in no event will we sell securities registered on our Form S-3 registration statement, including under our ATM, with a value of more than one-third of the aggregate market value of shares of our common stock held by non-affiliates in any 12-month period, so long as the aggregate market value of shares of our common stock held by non-affiliates is less than $75 million. After giving effect to the approximate $13,000,000 offering limit imposed by General Instruction I.B.6 of Form S-3 and deducting the shares sold within the preceding 12 months, approximately $3,700,000 of common stock remain available at this time for sale